VolitionRx Schedules Third Quarter 2026 Earnings Call and Business Update
VolitionRx Limited (NYSE AMERICAN: VNRX) has announced it will host a conference call on Friday, November 13, 2026, at 8:30 a.m. ET to discuss its financial and operating results for the third quarter of 2026. The call, hosted by CEO Cameron Reynolds and CFO Terig Hughes, will provide updates on Q3 activities, subsequent events, and upcoming corporate milestones. The company, which focuses on epigenetic-based blood tests for disease detection such as cancer and sepsis, intends to use the session to brief investors on its current business trajectory.
Topics: earnings call financial results quarterly update
Read the full article at PR Newswire
Part of the story Lowe's Companies to Host Third Quarter 2026 Earnings Conference Call on November 18 (5 articles)